Exxua: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年9月26日 · Exxua (gepirone) is an antidepressant used to treat major depressive disorder (MDD) in adults by working on serotonin levels in the brain. Includes Exxua dose, side effects, interactions, and more.
EXXUA is indicated for the treatment of major depressive disorder (MDD) in adults (1). Correct electrolyte abnormalities and perform electrocardiogram (ECG) prior to initiating treatment...
Exxua (gepirone): Uses, Side Effects, Dosage & Reviews - GoodRx
2024年4月15日 · Exxua (gepirone) is an antidepressant used to treat major depressive disorder (MDD) in adults. This medication is the first in a new class of antidepressants called 5HT1A receptor agonists. It works by balancing the activity of serotonin, a chemical in the brain that regulates mood.
Gepirone Finally Gets FDA OK as Depression Treatment
2024年3月25日 · Madhukar Trivedi, M.D., said that recently-approved Exxua (gepirone) may be a good option for individuals with anxious depression, given clinical trial findings and the medication’s chemical similarity to the anxiolytic buspirone.
Gepirone - Wikipedia
Gepirone, sold under the brand name Exxua, is a medication used for the treatment of major depressive disorder. [1] It is taken orally. [1] Side effects of gepirone include dizziness, nausea, insomnia, abdominal pain, and dyspepsia (indigestion). [1] Gepirone acts as a partial agonist of the serotonin 5-HT 1A receptor.
FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD
2023年9月29日 · Following a long path to approval, gepirone hydrochloride extended-release tablets (Exxua) is the first FDA-approved medication with this novel mechanism of action for adults with MDD.
A New Dawn: FDA Greenlights Exxua (Gepirone ER) for Major …
2024年1月29日 · In a significant stride towards advancing mental health treatment, the U.S. Food and Drug Administration (FDA) has recently approved Gepirone ER, a promising medication now available under the brand name Exxua.
Fabre-Kramer Pharmaceuticals Announces FDA Approval of EXXUA…
2023年9月28日 · EXXUA is a novel oral selective serotonin (5HT) 1a receptor agonist indicated for the treatment of major depressive disorder (MDD) in adults. Exxua is also being developed for other psychiatric disorders. INDICATIONS and IMPORTANT SAFETY INFORMATION for EXXUA (gepirone) extended-release tablets.
Exxua (gepirone) dosing, indications, interactions, adverse effects ...
Indicated for treatment of major depressive disorder (MDD) Initial: 18.2 mg PO qDay. Screen for a personal or family history of bipolar disorder, mania, or hypomania before initiating...
FDA Greenlights Exxua™ (Gepirone): A Promising New …
2024年3月4日 · Exxua represents a promising new antidepressant for Major Depressive Disorder (MDD) with a unique mechanism of action targeting the glutamatergic system. The drug gained FDA approval after years of research involving more than 5,000 patients.